United States
Securities and Exchange Commission
Washington, D.C. 20549

Schedule 13G

Under the Securities Exchange Act of 1934
(Amendment No. n/a )*

OMB Number
3235-0145

iShares Nasdaq Biotechnology Index
(Name of Issuer): Common Stock, par value $0.01 per share
(Title of Class of Securities): 464287556
(CUSIP Number): Calendar Year 2008
(Date of Event which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

	Rule 13d-1(b)
√	Rule 13d-1(c)
	Rule 13d-1(d)

* The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

CUSIP No.

Names of Reporting Persons.
I.R.S. Identification Nos. of above persons (entities only).
STICHTING PENSIOENFONDS ABP
98-0140331
Check the Appropriate Box if a Member of a Group (See Instructions)
SEC Use Only
Citizenship or Place of Organization
The Kingdom of the Netherlands

Number of Shares Beneficially Owned by Each Reporting Person With:

Sole Voting Power
0
Shared Voting Power
0
Sole Dispositive Power
0
Shared Dispositive Power
0

Aggregate Amount Beneficially Owned by Each Reporting Person
0
Check if the Aggregate Amount in Row 9 Excludes Certain Shares (See Instructions)
Percent of Class Represented by Amount in Row 9
0.00%
Type of Reporting Person (See Instructions)
N/A

Item 1.

Name of Issuer
iShares Nasdaq Biotechnology Index
Address of Issuer's Principal Executive Offices
Barclays Global Fund Advisors
45 Fremont Street
San Francisco, CA 94105

Item 2.

Name of Person Filing
Stichting Pensioenfonds ABP
Address of Principal Business Office or, if None, Residence
Oude Lindestraat 70, Postbus 2889, 6401 Dl Heerlen, The Kingdom of the Netherlands
Citizenship
The Kingdom of the Netherlands
Title of Class of Securities
Common Stock, par value $0.01 per share
CUSIP Number
464287556

Item 3. If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:

Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o).
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).
Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c).
Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C 80a-8).
An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E);
√ An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F);
A parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G);
A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
Group, in accordance with §240.13d-1(b)(1)(ii)(J).

Item 4. Ownership

Amount beneficially owned:
0
Percent of class:
0.00%
Number of shares as to which the person has:
1. Sole power to vote or to direct the vote:
  0
2. Shared power to vote or to direct the vote:
  0
3. Sole power to dispose or to direct the disposition of:
  0
4. Shared power to dispose or to direct the disposition of:
  0

Item 5. Ownership of Five Percent or Less of a Class

If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following .

Item 6. Ownership of More than Five Percent on Behalf of Another Person.

Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company

Item 8. Identification and Classification of Members of the Group

Item 9. Notice of Dissolution of Group

Item 10. Certification

Not applicable.

Signature

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

February 12, 2009
Date: Stichting Pensioenfonds ABP
/s/ Kim Killion
Signature: Kim Killion
Acting Chief Compliance Officer
Name / Title

NOTE: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See §240.13d-7 for other parties for whom copies are to be sent.

Attention: Intentional misstatements or omissions of fact constitute Federal criminal violations (See 18 U.S.C. 1001)

STICHTING PENSIOENFONDS ABP SC 13G